NeuroSense Therapeutics (NRSN) Net Shares Issued and Repurchased (2021 - 2025)
NeuroSense Therapeutics' (NRSN) quarterly Net Shares Issued and Repurchased came in at $118000.0 in Q4 2025, down 45.37% year-over-year from $216000.0 in Q4 2024, and down 45.37% quarter-over-quarter from $216000.0 in Q4 2024.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Net Shares Issued and Repurchased (2021 - 2025) Analysis & Trends
NeuroSense Therapeutics has disclosed Net Shares Issued and Repurchased across 4 years of filings, most recently posting $118000.0 for Q4 2025.
- In Q4 2025, Net Shares Issued and Repurchased fell 45.37% year-over-year to $118000.0; the TTM figure through Dec 2025 stood at $118000.0 (down 45.37% YoY), while the FY2025 annual figure was $118000.0, down 45.37% from the prior year.
- Net Shares Issued and Repurchased came in at $118000.0 for Q4 2025 at NeuroSense Therapeutics, down from $216000.0 in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $216000.0 in Q4 2024 to a low of $5000.0 in Q1 2022.
- Average Net Shares Issued and Repurchased over 4 years is $102750.0, with a median of $95000.0 recorded in 2021.
- The largest YoY upside for Net Shares Issued and Repurchased was 45.37% in 2025 against a maximum downside of 45.37% in 2025.
- Over 4 years, Net Shares Issued and Repurchased stood at $72000.0 in 2021, then slumped by 93.06% to $5000.0 in 2022, then soared by 4220.0% to $216000.0 in 2024, then sank by 45.37% to $118000.0 in 2025.
- Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $118000.0 in Q4 2025, $216000.0 in Q4 2024, and $5000.0 in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | - |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | - |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | 118,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 118,000.00 |
| Dec 31, 2024 | 216,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 72,000.00 |
API Access
NeuroSense Therapeutics Net Shares Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-shares-issued-and-repurchased", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();